Abstract-Insulin
I. INTRODUCTION
In intensive care unit (ICU), glycaemic controls is one of the main concern in giving treatment to critical patients especially for patients with diabetes. The patient with diabetes had greater mean of blood glucose and greater rates of hypoglycaemia compare to patients without diabetes [1] . From the previous study, hypoglycaemia and extreme hyperglycaemia should be avoid since these are correlated with mortality and higher risk of developing complication to critical patient in ICU [2] .
Therefore, significant of the intensive glycaemic management or protocol has been demonstrated in controlling of the blood glucose [3] . The purpose of glycaemic control protocol is as guidelines in monitoring patient with diabetes or without diabetes in ICU include preventing hyperglycaemia, hypoglycaemia and uncontrolled glycaemia. The blood glucose level of the critical patients (Malaysia cohort) should be in the target range which is between 4.4 -10.0 mmol/L. Generally, the continuously or hourly blood glucose, insulin infusion and feeding measurement are required in clinical standard protocol practise [4] .
The current protocol that implement at Hospital Tengku Ampuan Afzan (HTAA), Kuantan is intensive insulin therapy (IIT) for intravenous insulin treatment to achieve target range of blood glucose levels with continuous glucose testing and alteration of insulin doses. Several studies have proved that IIT can prevent the hyperglycaemia but highly risk of hypoglycaemia [5] [6] especially patients with hepatic or renal failure [7] .
Previous study, the optimal control glucose balance in ICU patient based on theoretical analysis model and numerical method was investigated to demonstrate the controllability and applicability of the model in predictions and control of hyperglycaemia and hypoglycaemia [8] . In Christchurch hospital, STAR (Stochastic TARgeted) has been adopted as a stochastic forecasting method in determine the optimal insulin nutrition protocol [9] . The STAR algorithm was provides a safe control and effective method for monitoring blood glucose of ICU patient, while it also can minimise the nursing workload [10] . The STAR protocol was improvement of the Specialised Relative Insulin Nutrition and Insulin Tables  (SPRINT) protocol. SPRINT protocol is the simple tight glycaemic control protocol that managed both insulin and nutrition input according to hourly blood glucose measurement [11] . In 2012, the studied of STAR development and protocol comparison show that STAR protocol reduces 79% of hypoglycaemia compare to SPRING protocol [10] .
This study is focused on the respond of the Malaysia cohort if the STAR protocol is used to replace the current protocol that practised in ICU of HTAA, Kuantan. Based on the respond of the Malaysia cohort will be modification and generalization of the model based tight glycaemic control according to the patient needs and clinical setting.
II. METHODOLOGY

A. Clinical data
The clinical data were collected from 210 critical patients treated at the Intensive Care Unit (ICU) of Hospital Tengku Ampuan Afzan (HTAA), Kuantan using Intensive insulin infusion therapy (IIT), between May 2014 and June 2015. Patient demographics are given in Table 1 .
In this study, the clinical data of the critical patients was treated with HTAA protocol used to generate virtual patient for virtual trial of STAR protocol; then virtual patient is employed to forecast the outcome of hourly blood glucose level for STAR protocol [12] .The virtual trials proposed to initiate the virtual patients by simulated the response of the STAR protocol and find out the performance before clinical testing of the STAR protocol at ICU of HTAA [10] . 
B. Hospital Tengku Ampuan Afzan (HTAA) protocol
The management protocol that have been practising in Intensive Care Unit of Hospital Tengku Ampuan Afzan for clinical data are Insulin Infusion and Enteral and Parenteral Nutrition [13] .The details of the HTAA management protocols are explain below:
1) Insulin Infusion Protocol
This protocol was start implement to the critical patient when the blood glucose level (BGL) greater than 10mmol/l for the continue reading within1 h. Then, soluble insulin 50 unit in 50 ml 0.9% NaCl is used for the continuous intravenous insulin infusion. To maintain the blood glucose level (BGL) in targeted range 4.4 to 10 mmol/L, blood glucose is monitoring by initially 1hours until glucose is within goal for 2hours, then 4hours.
The insulin infusion is depending on current and previous blood glucose level range. Table II 
2) Enteral and Parenteral Nutrition Protocol
Most of the critical patient is preferable give enteral nutrition compare to the parenteral nutrition. Therefore, in this study the parenteral nutrition is neglect.
The enteral nutrition is depending on the aspirates reading. Aspirate reading is measurement of gastric contents or fluid that withdraws from the body. Usually, enteral feeding starts after 24-48 hours of admittance in Intensive Care Unit (ICU). There is continuously feeding method of the enteral nutrition for critical patients:
a. The feeding is start at 20-40 mls/h continuously within 4 hours aspirate feeding tube. b. After 4 hours:
i. If aspirates less than 300mls/h, return all aspirates and increase the rate by 20mls/h every 2 cycles until it meets the patient caloric needs. ii. If aspirates greater than 300mls/h, return all aspirate to patient and reduce by 50% of initial rate.
C. Intensive Control Insulin Nutrition Glucose (ICING) Model
The Intensive Control Insulin Nutrition glucose model is a latest Glucose insulin physiology model [11] . This model consist of seven mathematical equation which is to identify the blood glucose concentration level, interstitial insulin concentration, plasma insulin concentration, Glucose level in gut , glucose level in stomach, enteral glucose input and endogenous insulin production. The mathematical model of ICING model is defined as below:
.
Where model nomenclatures can be referred as in [11] D. Virtual patients and trial simulation Figure 1 shows process of creates virtual patient data by using clinical data from intensive care unit of HTAA. The process are started by collection of raw data from HTAA, then used ICING model to fit the clinical data using integration based parameter and generate the insulin sensitivity profile for critical patient cohort. From the insulin sensitivity profile, identification of the virtual patients is obtained and virtual trial can be simulate to observe hourly blood glucose respond of the virtual patient cohort.
Next, the insulin sensitivity of the virtual patients is simulating again using ICING model and STAR controller. This trial simulation will come out with per-cohort and perpatient statistic of insulin rate, dextrose rate and percentage of hourly blood glucose. The STAR controller used sensitivity of insulin to project the next approximate of patient treatment [14] Raw clinical data of HTAA protocol For the virtual trial simulation, STAR protocol is used to monitor the hourly blood glucose and nutrition feeding of the patient. The entry criteria of the STAR protocol is blood glucose reading is higher than 10 mmol/L within 4 hour [14] . For this protocol, nurse could be freely selecting the next measurement of blood glucose either within interval of 1, 2, or 3 hour when blood glucose in the targeted band [12] .
E. Analysis
The percentage of blood glucose within targeted 4.4-10.0 mmol/L will represent the performance of the protocol. The performance of the STAR protocol was compared with the performance of the HTAA ICU protocol. Furthermore, the result of this study is discuses based on median and interquartile of the blood glucose between current protocol and STAR protocol.
Since the blood glucose and insulin reading is typically skewed distribution data, nonparametric statistics are used for all comparative test in this study. In addition, the KolmogorovSmirnov test is used to calculate the p-value for all the continuous data. Results for all tests are considered statistically significant if the P-value less than 0.05. Table I shows the demographic of HTAA clinical data and STAR cohort have no significant diference in gender, BMI, age, ICU category and also ethnicity. Both data are from the same source of HTAA clinical ICU patients. However, based on the result in Table III , it can be seen that from 210 samples, the number of patient with BG < 2.22 mmol/L increases up to 36 patients for STAR, while only 9 patients for HTAA Protocol. While for the median of BG it is decreasing from 8.6 mmol/L to 7.4 mmol/L. These shows that STAR gives a significant result compared to HTAA Protocol.
III. RESULT
Besides, the results for STAR simulation is also providing a significant difference of output in the total hours and BG numbers. Total hours is the overall measurements of hours taken for the whole cohort of ICU patients while BG numbers is the sum BG recorded for all 210 patients. As shown in Table  III , total hours is decreasing from 26727 hrs (HTAA) to 26617 hrs (STAR) and the BG numbers increasing from 13011 (HTAA) to 17340 (STAR).
The most important outcome that have to be concerned of comparing these two protocols is the percentage of the patient within targeted band of BG level, where is between 4. The increment of patient with % BG level within 4.4-10.0 mmol/L is highly related to the reduction of severe hyperglycaemic issue. Severe hyperglycaemia is the case where the % BG level of the patient is greater than 10.0 mmol/L. Referred to Table III, the % BG level is decreases from 32.8% (HTAA) to 19.7% (STAR).
From the result of % BG level > 10.0 mmol/L and % BG within targeted band, it can be concluded that STAR protocol is successful in lowering the BG level. The drawback of this result is the increasing of hypoglycaemia patients. It can be observed clearly under % BG < 2.22 mmol/L and number of patients < 2.22 mmol/L. Several factor and solution have been analysed to overcome this issue and will be explained affterwards.
On the second part of analysis, the comparison is involving the median of patient's variable for two protocols (HTAA and STAR) which are still in sample size of 210 patients. The data calculated by its median to undergo non-parametric test because it is not confirmed to have a normal distribution. Nonparametric statistics are used exclusively for all the comparative tests due to the typically skewed distributions of BG, insulin dose and other data. Using kolmogorov-smirnov analysis (kstest), p-value has been calculated and the value is recorded fourth column in Table III . Only two variables analysed here which are BG level and plasma insulin concentration (I). For both variable, BG level and plasma insulin concentration (I), they are having p-value less than significant level (0.05), which indicate that there is significant difference between HTAA and STAR Protocol data. This analysis shows the null hypothesis is rejected. The outcome of p-value strengthen and proven the expected results (STAR is a better protocol than HTAA). Protocol. An inverse result obtained for plasma insulin concentration which is STAR Protocol is lower than HTAA Protocol. Not only for the graph, the whole cohort statistics (refer to  Table III ) of median insulin rate and median glucose rate show the same behaviour with the data represented in graph. For median insulin rate, it is increasing from 2.0 (HTAA) to 5.0 (STAR) and for median glucose rate, it is decreasing from 4.1 (HTAA) to 3.9 (STAR).
The error between two methods (HTAA and STAR) were recorded in the boxplot as shown in Figure 5 . The boxplot is constructed from the mean difference which is calculated based on HTAA/STAR data & raw data. It is clearly shown that STAR protocol has higher accuracy in terms of BG measurements compared to HTAA Protocol.
From all the statistics and data featured, STAR virtual trials has the safest, with an effective AGC in HTAA clinical ICU data. STAR protocol has successfully lowering down the BG level and associated with raising up the plasma insulin concentration. As already known, BG level is positively proportional to plasma insulin concentration which is whenever the plasma insulin concentration is increase, the BG level will increase and vice versa.
STAR is said to be a way more better than HTAA Protocol because from the hyperglycaemic cases (the % BG > 10.0 mmol/L) of STAR is lower than HTAA Protocol. Therefore the objective of introducing the STAR protocol to lower down BG level together with decreasing hyperglycaemia issue is accomplished. Simultaneously, the targeted band of BG level, where % BG within 4.4 -10.0 mmol/L for STAR virtual trial is higher than HTAA virtual patient. The increases of % BG within targeted band are the impact of decreasing in percentage of hyperglycaemic band.
However, the drawback of decreasing patients' BG level is hypoglycaemia. This can be found from Table III which is for the number of patients < 2.22 mmol/L, the result is increases from 9 (HTAA Protocol) to 36 (STAR). Hypoglycaemia is a serious issue because its leads to mortality and the patients have less chance to survive.
One of the factor increasing the hypoglycaemic issue in STAR is due to high BG variability in HTAA clinical ICU data and resulting the unstable insulin sensitivity, SI. Yet hypoglycaemia can be fixed by introducing the nutrition together in HTAA protocol.
Current protocol applied in HTAA is organising the nutrition separated from insulin infusion. Thus it may disrupt the SI and also hypoglycaemia. Besides, the multiple types of nutrition that is found in nutrition protocol like glucerna, peptamen, ensure, and nepro also may lead to the diturbance of SI. The usage of different types of nutrition is to match it with the different behaviour of the patients. A study to analyse the effect of implying the different types of nutrition on SI is needed to improve this problem.
Another factor of hypoglycaemia is the trade-off between measurement rate, which highly related to nursing workload and patient safety of STAR and HTAA Protocol comparison. However the result (% BG level < 2.22 mmol/L) can be controlled by measurement interval options means that an informed decision can be made at each BG reading. The great difference between STAR and HTAA Protocol is the ability to change the desired target range and other factors or limits. This advantage enable the balancing between workload and safety as previously explained.
Insulin sensitivity is based on HTAA clinical ICU data and it is calculated for each patients of the data taken, or can be said patient specific. STAR virtual trial is been simulated by referring to this insulin sensitivity to calculate the value of BG level and plasma insulin concentration, I. Basically, this is the flow or steps on the designation of virtual trial. As the results are obtained, the performance of STAR need to be compared with HTAA Protocol.
IV. CONCLUSION
Overall, it can be concluded that STAR provides a better results and outcome in controlling the BG levels and reducing the risks of hyperglycaemia compared to HTAA Protocol. Moreover, it is consistently balanced the patient safety and nursing workload. However, in reply of reducing the BG level, STAR is potentially increasing the hypoglycaemic issue but it is probably happened due to unstable SI. Besides, hypoglycaemic issue also might be related to the isolation of nutrition protocol and insulin infusion protocol. Further studies will be done in order to find out the actual causes.
